2-Apr-2026 Top cancer scientist Thales “PapaG” Papagiannakopoulos joins Salk Institute Salk Institute Business Announcement
2-Apr-2026 A small molecule drug candidate fully restores survival in a lethal mouse model of a rare kidney stone disease that has no current treatment Buck Institute for Research on Aging Peer-Reviewed Publication
2-Apr-2026 Reprogramming ‘gatekeeper’ immune cell may boost cancer immunotherapy St. Jude Children's Research Hospital Peer-Reviewed Publication
2-Apr-2026 Prize winner’s research reprograms tumor cells to trigger antitumor immunity American Association for the Advancement of Science (AAAS) Grant and Award Announcement
2-Apr-2026 Radiation therapy improves outcomes for 'supermassive’ bile duct tumors University of Texas M. D. Anderson Cancer Center Peer-Reviewed Publication
2-Apr-2026 The University of Colorado Anschutz Gates Institute achieves first-in-U.S. FDA clearance for campus-built CAR T-cell therapy University of Colorado Anschutz Business Announcement
2-Apr-2026 Leukemia study restores silenced gene in mice. Could it point to new treatments for humans? Jackson Laboratory Peer-Reviewed Publication
2-Apr-2026 A redesigned endoscope offers a new way to look for early signs of ovarian cancer SPIE--International Society for Optics and Photonics Peer-Reviewed Publication
2-Apr-2026 How pancreatic tumors thwart an iron-driven demise Ludwig Institute for Cancer Research Peer-Reviewed Publication
2-Apr-2026 Study: Biomarker test may improve risk assessment for HPV-related throat cancer Ohio State University Wexner Medical Center Peer-Reviewed Publication